SRR6079994
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
- sex
- female
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
7 twins match this tumor's tissue · 3 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR1516074 | — | — | 0.845 |
| 2 | BS_V7BJM89K | low-grade glioma | — | 0.839 |
| 3 | MDT-AP-0373 | Med | Medulloblastoma | 0.830 |
| 4 | SRR1313097 | — | A | 0.826 |
| 5 | TCGA-97-A4M1-01A-11R-A24X-07 | — | cohortA1 | 0.821 |
| 6 | TCGA-OL-A5DA-01A-11R-A27Q-07 | — | B | 0.816 |
| 7 | TCGA-55-8097-01A-11R-2241-07 | — | cohortA1 | 0.816 |
| 8 | C3L-00444 | — | cohortA1 | 0.815 |
| 9 | C3L-02958 | — | cohortA1 | 0.813 |
| 10 | MDT-AP-1121 | Med | Medulloblastoma | 0.807 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 12 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| P53_PATHWAY | 0.250 | Idelalisib | — uncovered |
| WNT_BETA_CATENIN_SIGNALING | 0.160 | Inavolisib | — uncovered |
| KRAS_SIGNALING_DN | 0.140 | Remibrutinib | — uncovered |
| MYOGENESIS | 0.130 | Inavolisib | — uncovered |
| TGF_BETA_SIGNALING | 0.090 | Inavolisib | — uncovered |
| PANCREAS_BETA_CELLS | 0.080 | Cobimetinib | — uncovered |
| XENOBIOTIC_METABOLISM | 0.060 | Inavolisib | — uncovered |
| COAGULATION | 0.020 | Binimetinib | — uncovered |
| ESTROGEN_RESPONSE_EARLY | 0.020 | Inavolisib | — uncovered |
| INFLAMMATORY_RESPONSE | 0.020 | Idelalisib | — uncovered |
| BILE_ACID_METABOLISM | 0.010 | Inavolisib | — uncovered |
| CHOLESTEROL_HOMEOSTASIS | 0.010 | Remibrutinib | — uncovered |